Prostate Cancer - Results from #22640

The role of focal therapy in the management of localised prostate cancer: A systematic review - Abstract July 30, 2013

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population - Abstract July 30, 2013

Pathologic examination of radical prostatectomies in men with very-low-risk disease at biopsy reveals distinct zonal distribution of cancer in African American men - Abstract July 30, 2013

PSA screening for prostate cancer: Why so much controversy? - Abstract July 30, 2013

GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update - Abstract July 30, 2013

Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: A standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics - Abstract July 30, 2013

A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study - Abstract July 30, 2013

Major changes urged for cancer screening and treatment July 30, 2013

Radium-223 chloride (Alpharadin) in patients with bone metastases and castration-resistant prostate cancer (CRPC): A new treatment paradigm - Video lecture by A. Oliver Sartor, MD July 29, 2013

Defining a new testosterone threshold for medical castration: Results from a prospective cohort series - Abstract July 29, 2013

Prostate cancer-specific survival differences in patients treated by radical prostatectomy versus curative radiotherapy - Abstract July 29, 2013

The modified Glasgow prognostic score in prostate cancer: Results from a retrospective clinical series of 744 patients - Abstract July 29, 2013

Abdominal wall haemorrhage after robotic-assisted radical prostatectomy: Is it a complication of robotic surgery? - Abstract July 29, 2013

Transrectal saturation technique may improve cancer detection as an initial prostate biopsy strategy in men with prostate-specific antigen July 29, 2013

Repetitively dosed docetaxel and (153)samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer - Abstract July 29, 2013

FDA Drug Safety Communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems July 29, 2013

Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer - Abstract July 29, 2013

Hypofractionation for clinically localized prostate cancer - Abstract July 29, 2013

Management of prostate cancer in elderly men - Abstract July 29, 2013

Takeda announces unblinding of phase 3 study of orteronel in patients with metastatic, castration-resistant prostate cancer that progressed post-chemotherapy based on interim analysis July 27, 2013

Page 1133 of 1436